Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.59457 | 24 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.53183 | 23 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.53491 | 23 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.44935 | 21 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.46967 | 22 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.63413 | 24 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.66769 | 27 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.50307 | 22 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.48831 | 22 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.50714 | 22 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.51605 | 23 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.49178 | 22 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.53233 | 23 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.52523 | 23 |